Helen Sabzevari insider trades

Open-market stock purchases and sales by Helen Sabzevari, President and CEO at Precigen, Inc, from SEC Form 4 filings since Jan 2, 2018.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +265%.

Recent trades

DateStockTradeValue
Aug 23, 2026PGEN Precigen, IncBought (not open market)—
Aug 23, 2026PGEN Precigen, IncSold (not open market)$73.3K
Aug 23, 2026PGEN Precigen, IncBought (not open market)—
Jun 29, 2026PGEN Precigen, IncSold$2M
Jun 29, 2026PGEN Precigen, IncBought (not open market)$808K
Jun 29, 2026PGEN Precigen, IncBought (not open market)—
May 28, 2026PGEN Precigen, IncSold$520K
May 23, 2026PGEN Precigen, IncBought (not open market)—
Apr 20, 2026PGEN Precigen, IncBought (not open market)—
Apr 20, 2026PGEN Precigen, IncBought (not open market)—
Mar 18, 2026PGEN Precigen, IncBought (not open market)—
Mar 18, 2026PGEN Precigen, IncBought (not open market)—

Companies traded

  • PGEN Precigen, Inc: 1 buy, 18 sales, last Aug 23, 2026
  • KNTE Kinnate Biopharma Inc: other filings, last Apr 3, 2024
  • XON Intrexon Corp: 7 sales, last Jan 6, 2020

Get free alerts when Helen Sabzevari files a new trade →